Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.9050 (0.71%) ($9.9050 - $9.9050) on Tue. Nov. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.91% (three month average) | RSI | 44 | Latest Price | $9.9050(0.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.7% a day on average for past five trading days. | Weekly Trend | EDIT declines -8.8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(58%) IWC(53%) IWO(50%) IWM(49%) IWN(47%) | Factors Impacting EDIT price | EDIT will decline at least -2.455% in a week (0% probabilities). VIXM(-13%) VXX(-9%) XLU(-4%) XBI(-4%) SMH(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.455% (StdDev 4.91%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-7.8(-178.75%) | Resistance Level | $11.37 | 5 Day Moving Average | $10.12(-2.12%) | 10 Day Moving Average | $10.74(-7.77%) | 20 Day Moving Average | $11.37(-12.88%) | To recent high | -38.8% | To recent low | 0.7% | Market Cap | $615m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |